ImmunoMolecular Therapeutics, Inc. — SBIR/STTR Competitive Profile
Aggregate SBIR/STTR award history for ImmunoMolecular Therapeutics, Inc., built entirely from public federal award records. Free competitive intelligence — no login required.
- 1 award
- $224,991 total on record
- 1 agency
- 1 Phase I · 0 Phase II
Phase mix
- Phase I — 1 award
Funding agencies
Awards by year
- 2018 — 1 award
Places of performance
Firms like ImmunoMolecular Therapeutics, Inc.
See the companies with the most overlapping technology domains and funding agencies, ranked by a weighted-overlap similarity score.
Sign in to see firms like this
The full similar-firms list is free with an account. Sign in or create a free account to compare competitors.
Recent awards
| Award | Agency | Amount | Program | Start |
|---|---|---|---|---|
| 1R43DK117703-01A1 | Department of Health and Human Services | $224,991 | SBIR · Phase I | 2018-09-17 |
Frequently asked questions
How many SBIR/STTR awards has ImmunoMolecular Therapeutics, Inc. won?
ImmunoMolecular Therapeutics, Inc. has won 1 SBIR/STTR award worth $224,991 in the public federal award records SBIR Signal tracks, including 1 Phase I and 0 Phase II award(s).
Which agencies fund ImmunoMolecular Therapeutics, Inc.?
ImmunoMolecular Therapeutics, Inc.'s awards come from 1 agency on record; its top funder is Department of Health and Human Services.
What technology areas does ImmunoMolecular Therapeutics, Inc. work in?
Based on its award history, ImmunoMolecular Therapeutics, Inc. works in a range of technology areas.
How do I find firms similar to ImmunoMolecular Therapeutics, Inc.?
Sign in and open the 'firms like this' view on the profile to see the companies with the most overlapping technology domains and funding agencies.